Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yanjun Zhu
Observed names:
Y. Zhu,
Yan-Jun Zhu,
YanJun Zhu,
Zhu, Yanjun
Institutions:
Henan University of Chinese Medicine,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Henan University of Chinese Medicine,
Fudan University,
Zhongshan Hospital,
University of California Davis Medical Center,
Henan Normal University,
University of California, Davis
show all 7
ORCID:
0000-0001-8574-6351
Observed ORCID:
0000-0001-8574-6351
OpenAlex ID:
A5017847020
Circular RNA Expression Profiling Identifies Prostate Cancer- Specific circRNAs in Prostate Cancer
2018
·
Qianlin Xia
, Tao Ding
, et al.
·
Cellular Physiology and Biochemistry
·
97
PDF
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer
2017
·
Shu-Xiong Zeng
, Yanjun Zhu
, et al.
·
Clinical Cancer Research
·
63
Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
2018
·
Jiaxi Yao
, Wei Xi
, et al.
·
Cancer Management and Research
·
57
PDF
Circular RNA circ_0057558 Controls Prostate Cancer Cell Proliferation Through Regulating miR-206/USP33/c-Myc Axis
2021
·
Tao Ding
, Yanjun Zhu
, et al.
·
Frontiers in Cell and Developmental Biology
·
43
PDF
Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies
2017
·
Menglin Shan
, Qianlin Xia
, et al.
·
Oncotarget
·
29
PDF
A Prospective Randomized Controlled Trial of the Efficacy of External Physical Vibration Lithecbole after Extracorporeal Shock Wave Lithotripsy for a Lower Pole Renal Stone Less Than 2 cm
2015
·
Qilai Long
, Jian Zhang
, et al.
·
The Journal of Urology
·
28
Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia
2019
·
Tzu-yin Lin
, Yanjun Zhu
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
24
STK39 blockage by RNA interference inhibits the proliferation and induces the apoptosis of renal cell carcinoma
2018
·
Qi Zhao
, Yanjun Zhu
, et al.
·
OncoTargets and Therapy
·
24
PDF
Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour‐infiltrating lymphocytes
2020
·
Jiaxi Yao
, Wei Xi
, et al.
·
Scandinavian Journal of Immunology
·
20
PDF
HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinoma
2023
·
Xianglai Xu
, Sihong Zhang
, et al.
·
Cancer Medicine
·
17
PDF
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer
2025
·
Tao Ding
, Lina He
, et al.
·
Chinese Journal of Cancer Research
·
15
Does intraoperative cyst rupture of malignant cystic renal masses really have no negative impact on oncologic outcomes?
2022
·
Peirong Xu
, Sihong Zhang
, et al.
·
World Journal of Surgical Oncology
·
15
PDF
Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell Carcinoma
2022
·
Jiajun Wang
, Sihong Zhang
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
15
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients
2023
·
Xianglai Xu
, Ying Wang
, et al.
·
Neoplasia
·
14
Development and prospective validation of a novel weighted quantitative scoring system aimed at predicting the pathological features of cystic renal masses
2018
·
Yaohui Li
, Chenchen Dai
, et al.
·
European Radiology
·
14
Circular RNA-DPP4 serves an oncogenic role in prostate cancer progression through regulating miR-195/cyclin D1 axis
2021
·
Deping Yang
, Bo Yang
, et al.
·
Cancer Cell International
·
12
PDF
The zero ischemia index (ZII): a novel criterion for predicting complexity and outcomes of off-clamp partial nephrectomy
2016
·
Yaohui Li
, Lin Zhou
, et al.
·
World Journal of Urology
·
11
Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expression
2022
·
Xianglai Xu
, Ying Wang
, et al.
·
Immunogenetics
·
10
Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study
2022
·
Peirong Xu
, Sihong Zhang
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
10
PDF
Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
2018
·
Jia-Xi Yao
, Xiang Chen
, et al.
·
Journal of Cancer
·
9
PDF
Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics
2021
·
Xianglai Xu
, Yelin Wang
, et al.
·
Evolutionary Bioinformatics
·
8
A highly sensitive near-infrared fluorescent probe for intelligent visual detection of Cu2+ in water/vegetables and bioimaging in vitro and in vivo
2025
·
Yan-Jun Zhu
, Pan Pan
, et al.
·
Dyes and Pigments
·
7
PSMD2 overexpression as a biomarker for resistance and prognosis in renal cell carcinoma treated with immune checkpoint and tyrosine kinase inhibitors
2024
·
Xianglai Xu
, Jiahao Wang
, et al.
·
Cellular Oncology
·
6
Effect of galectin‐1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
2024
·
Jiajun Wang
, Sihong Zhang
, et al.
·
Cancer Medicine
·
6
PDF
Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
2021
·
Sihong Zhang
, Xianglai Xu
, et al.
·
PubMed
·
6
Show more works
View as search
Works count:
47
Citation count:
600
H-index:
14
I10-index:
19
Year
Topic
Type